| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.00032 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.00025 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.00027 | 1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.00018 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.00012 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -7.2e-06 | 1 |